Recall: D-1293-2019

Class I - Dangerous

Class IClassification

2019-04-30Initiated

TerminatedStatus

Par Pharmaceutical, Inc.Firm

Product

Mycophenolate Mofetil for Injection, USP 500 mg, 4 Single Dose Vials, Rx Only, Distributed by: Par Pharmaceutical Chestnut Ridge, NY 10977 NDC 342023-172-044

Reason

Presence of Particulate Matter; glass fragment observed in one vial of reconstituted product

Distribution

nationwide

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.